Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEland Oil & Gas Regulatory News (ELA)

  • There is currently no data for ELA

Replacement - Quarterly Update

31 Mar 2017 07:38

RNS Number : 1336B
Eland Oil & Gas PLC
31 March 2017
 

 

31 March 2017

 

Eland Oil & Gas PLC

 ("Eland" or the "Company")

 

Correction: Quarterly Update

 

This announcement replaces the previous release made on 31 March 2017 under RNS number 1326B.

The previous announcement stated the Company is planning to commence the workover and side-track of Opuama-7 by the end of H2 2017.

 

This should have stated that that The Company is planning to commence the workover and side-track of Opuama-7 by the end of H1 2017.

 

This is the only change to the previously released announcement. The correction is included in the full text of the announcement below.

 

 

Eland Oil & Gas PLC (AIM: ELA), an oil & gas development and exploration company operating in West Africa with an initial focus on Nigeria, is pleased to announce a quarterly update of its operations.

 

Following recommencement of production in January, OML 40 has now produced over 330,000 barrels of oil, from the Opuama-3 well only. Following choking back of Opuama-3 for testing and reservoir optimisation average production for full producing days since recommencement of production has been approximately 8,000 bopd.

 

To this date over 160,000 barrels of oil have been delivered to the export terminal with approximately a further 160,000 barrels ready for imminent injection. The Company has monetised 154,173 barrels of crude at an average price of $52.14 per barrel, with cash receipts of over $8 million. The Company expects to monetise the next 160,000 barrels in the coming weeks.

 

Production was temporarily halted to allow maintenance on the FPSO. The Company, having already produced 330,000 barrels, has used this opportunity to review the performance of the shipping operation. Modifications of the mooring system have since been implemented to cater for the tides and increased volumes being delivered to the storage tanker. The Company expects to resume production by the end of next week.

 

Water handling at Opuama field will commence in April through the installation of a three-phase separator, allowing the commencement of production from well Opuama-1. Production is expected to be about 11,500 bopd from Opuama-1 and Opuama-3 following the resumption of production and optimising.

 

The Company maintains a healthy cash balance at $9MM currently and is in the process of finalizing its semi-annual Borrowing Base review, targeting no change to borrowing levels and debt availability.

 

The Company is planning to commence the workover and side-track of Opuama-7 by the end of H1 2017, which we anticipate will initially add an additional 6,000 bopd to OML 40 production. We also expect to commence the workover of Gbetiokun-1 in H2 2017, which we expect will deliver at least a further 7,800 bopd to production. Furthermore, the Company expects to begin development of the Ubima early production system at the end of the Nigerian wet season in September and upon completion of road and wellsite preparation.

 

Following on from its assessment of the production potential of Gbetiokun-1 and the associated CPR by NSAI, effective 30 March 2016, Eland has carried out an integrated technical evaluation of a full development of the Gbetiokun field. An initial development comprising six new production wells targeting the deeper reservoirs, together with Gbetiokun-1, is forecast to produce more than 50 MMB. A second phase of development, comprising six further production wells targeting the shallower reservoirs, has the potential to produce a further 15 MMB. Eland's reservoir models indicate that these wells could deliver a peak production rate of over 50,000 bopd.

 

Eland will be presenting at Stifel's Nigerian Investor Conference today. The presentation is now available to view on the Company's website: http://www.elandoilandgas.com/.

 

 

 

George Maxwell, CEO of Eland, commented:

"The achievement of getting 120m ocean going oil tankers to run a continuous cycle through the Nigerian river system should not be underestimated and whilst we will continue to implement operational efficiency we could not be more delighted and excited with the way it has begun.

 

The success of establishing an alternative export route has considerably de-risked our crude monetisation and has ensured that we will never again have lengthy production downtime that resulted from a single route to market.

 

2017 brings huge opportunity for us to significantly increase production, capitalising on our earlier success from the re-entry programs, prior to new drilling opportunities."

 

 

 

In accordance with the guidelines of the AIM Market of the London Stock Exchange, John Downey, a geologist and Eland's Chief Technical Officer, who has a BSc from Nottingham University, an MSc from Leeds University and has over 30 years of relevant experience in the upstream oil and gas industry and who is a member of the Society of Petroleum Engineers and meets the criteria of qualified person under the AIM guidance note for mining and oil and gas companies, has reviewed and approved the technical information contained in this announcement.

 

 

-ENDS-

For further information:

 

Eland Oil & Gas PLC (+44 (0)1224 737300)

www.elandoilandgas.com

George Maxwell, CEO

Olivier Serra, CFO

Finlay Thomson, IR

 

Canaccord Genuity Limited (+44 (0)20 7 523 8000)

Henry Fitzgerald O'Connor

Nilesh Patel

 

Panmure Gordon (UK) Limited (+44 (0)20 7 886 2500)

Adam James / Atholl Tweedie

Tom Salvesen

 

Camarco (+44 (0) 203 757 4980)

Billy Clegg / Georgia Edmonds

 

Notes to editors:

Eland Oil & Gas is an AIM-listed independent oil and gas company focused on production and development in West Africa, particularly the highly prolific Niger Delta region of Nigeria.

Through its joint venture company Elcrest, Eland's core asset is OML 40 which is located in the Northwest Niger Delta approximately 75km northwest of Warri and has an area of 498km². In addition, the Company has a 40% interest in the Ubima Field, onshore Niger Delta, in the northern part of Rivers State.

The OML 40 licence holds gross 2P reserves of 83.2 mmbbls, gross 2C contingent resources of 41.2 mmbbls and a best estimate of 254.5 mmbbls of gross unrisked prospective resources. The Ubima field holds gross 2P reserves of 2.4 mmbbl of oil and gross 2C resource estimates of 31.1 mmbbl.

 

Forward-looking statements

This report has been prepared to provide additional information to shareholders to assess the Group's strategies and the potential for those strategies to succeed. The Statement should not be relied on by any other party or for any other purpose.

The report contains certain forward-looking statements. These statements are made by the directors in good faith based on the information available to them up to the time of their approval of this report but such statements should be treated with caution due to the inherent uncertainties, including both economic and business risk factors, underlying any such forward-looking information.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

US$

United States Dollars

%

Percent

bbl / bbls

barrel / barrels

BOPD

Barrels of Oil Per Day

CPR

The reserves and resources evaluation provided by Netherland, Sewell & Associates Inc. as at 31 March 2016

FPSO

Floating Production Storage and Offloading

Gbetiokun

Gbetiokun Field, OML 40

MMB

Million barrels

NPV15

Net Present Value at 15% Weighted Average Cost of Capital

NSAI

Netherland Sewell & Associates Inc

OML 40

Oil Mining Lease 40

Opuama

Opuama Field, OML 40

P50 Reserves

Reserves having a 50% certainty of being produced. These reserves are also referred to as "2P" (proven plus probable).

STOIIP

Stock Tank Oil Initially In Place

Ubima

Ubima Field, OML 17

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEAKDFDDDXEEF
Date   Source Headline
15th Nov 20062:50 pmRNSAnnual Report
25th Oct 20062:18 pmRNSBlocklisting Interim Review
25th Oct 20067:30 amBUSElan Reports Third Quarter 2006 Financial Results
24th Oct 20061:00 pmBUSTYSABRI(R) Maintained Remission in Patients with Moderate-to-Severe Crohn's Disease Treated for Longer Than Two Years According to Data Presented This Week
18th Oct 20068:42 amRNSHolding in Company
10th Oct 20067:00 amBUSNotice of Results
6th Oct 20062:07 pmBUSNew Pharmacoeconomic Data on TYSABRI(R) Demonstrate Significant Reduction in Steroid Use and Hospitalizations in Patients with Multiple Sclerosis
4th Oct 20061:00 pmBUSHealth Canada Grants Approval of TYSABRI(TM) (natalizumab) for the Treatment of Multiple Sclerosis Following Priority Review
29th Sep 20062:00 pmBUSNew Data Presented at ECTRIMS Congress Show TYSABRI(R) Has Sustained Effect on Relapse Rate in Multiple Sclerosis Patients Treated for up to Three Years
11th Sep 200611:57 amRNSFinancial Statements
9th Aug 20068:58 amRNSHolding in Company
2nd Aug 20065:26 pmRNSDirector/PDMR Shareholding
2nd Aug 200612:12 pmRNSHolding in Company
29th Jun 200612:32 pmRNSHolding in Company
21st Jun 200610:01 amRNSHolding in Company
15th Jun 20068:20 amRNSHolding in Company
7th Jun 20068:02 amRNSFurther re Appointment
1st Jun 200611:58 amRNSHolding in Company
25th May 20063:31 pmRNSHolding in Companies
25th May 200612:37 pmRNSHolding in Company
19th May 20065:51 pmRNSDirectors/PDMR Shareholding
19th May 200610:56 amRNSHolding in Company
17th May 200612:16 pmRNSHolding in Company
12th May 20061:45 pmRNSDirector/PDMR Shareholding
24th Apr 200611:36 amRNSHolding in Company
20th Apr 20064:44 pmRNSDocument Availability
19th Apr 20063:30 pmRNSHolding in Company
13th Apr 200612:51 pmRNSHolding in Company
13th Apr 200612:04 pmRNSAnnual Information Update
10th Apr 200612:42 pmRNSBrochure of Particulars
3rd Apr 20063:39 pmRNSBrochure of Particulars
13th Mar 200611:47 amRNSHoldings in Company
10th Mar 20063:24 pmRNSDirector/PDMR Shareholding
9th Mar 20067:30 amRNSRestoration of Listing
9th Mar 20067:01 amRNSOL Notice - Restoration
7th Mar 20061:00 pmRNSSuspension - Elan Corp Plc
7th Mar 20061:00 pmRNSOL Notice - Suspension
15th Feb 200610:15 amRNSBrochure of Particulars
10th Feb 20064:55 pmRNSDirector/PDMR Shareholding
9th Feb 20065:32 pmRNSDirector/PDMR Shareholding
9th Feb 20063:54 pmRNSHolding in Company
8th Feb 200610:56 amRNSDirector/PDMR Shareholding
3rd Feb 20069:58 amRNSDirector/PDMR Shareholding
25th Jan 200611:19 amRNSHolding in Company
9th Dec 20054:02 pmRNSDirector/PDMR Shareholding
17th Nov 20052:31 pmRNSRE:Director/PDMR Shareholding
1st Nov 20055:32 pmRNSDirector/PDMR Shareholding
22nd Sep 20059:43 amRNSRe: Brochure of Particulars
23rd Aug 20055:12 pmRNSDirector/PDMR Shareholding
21st Jun 200511:32 amRNSBrochure of Particulars

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.